Literatur
- 1
Grigor C, Capell H, Stirling A. et al .
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA
study): a single-blind randomised controlled trial.
Lancet.
2004;
364
263-269
- 2
Hetland M L, Stengaard-Petersen K, Junker P. et al .
Excellent treatment response to aggressive combination therapy in early rheumatoid
arthritis. An Investigator-initiated randomised, controlled, double-blind study of
methotrexate, intraarticular steroid and cyclosporine/placebo (CIMESTRA).
Arthritis Rheum.
2004;
50
(Suppl)
237
- 3
Korpela M, Laasonen L, Hannonen P. et al .
Retardation of joint damage in patients with early rheumatoid arthritis by initial
aggressive treatment with disease-modifying antirheumatic drugs: five-year experience
from the FIN-RACo study.
Arthritis Rheum.
2004;
50
2072-2081
- 4
Landewe R BM, Boers M, Verhoeven R C. et al .
COBRA combination therapy in patients with early rheumatoid arthritis. Long-term structural
benefits of a brief intervention.
Arthritis Rheum.
2002;
46
347-356
- 5
Pincus T, Yazici Y, Sokka T. et al .
Methotrexate as the anchor drug for the treatment of early rheumatoid arthritis.
Clin Exp Rheumatol.
2003;
21
(Suppl 31)
S179-S185
Prof. Dr. Klaus Krüger
Praxiszentrum St.Bonifatius, Rheumazentrum München
St. Bonifatiusstraße 5
81541 München
Email: klaus.krueger@med.uni-muenchen.de
